Skip to main content

Table 4 Incidence of Post embolism syndrome after TACE

From: Efficacy and safety analysis of dexamethasone-lipiodol emulsion in prevention of post-embolization syndrome after TACE: a retrospective analysis

 

Group

Chi-square test (P value)

TACE (N = 133)

TACE + Dexamethasone (N = 122)

Pearson Chi-Square

Fisher's exact test

Abdominal pain

 No

  Count (%)

59 (44.4%)

78 (63.9%)

0.002

0.002

 Yes

  Count (%)

74 (55.6%)

44 (36.1%)

  

Fever

 No

  Count (%)

83 (62.4%)

106 (86.9%)

0.000

0.000

 Yes

 Count (%)

50 (37.6%)

16 (13.1%)

  

Nausea

 No

  Count (%)

52 (39.1%)

72 (59.0%)

0.001

0.002

 Yes

  Count (%)

81 (60.9%)

50 (41.0%)

  

Vomiting

 No

  Count (%)

69 (51.9%)

96 (78.7%)

0.000

0.000

 Yes

  Count (%)

64 (48.1%)

26 (21.3%)